«Терминальная сердечная недостаточность.
Отбор пациентов для постановки в» лист ожидания «на трансплантацию сердца»
Диссертация
Для практической реализации этих задач необходима совместная работа кардиологов на местах со специализированными хирургическими центрами с целью: ранней диагностики и начала терапии направленной на лечение ХСН, ^ направление пациента на хирургическое лечение, до развития необратимых признаков поражения органов мишеней, ^ своевременный отбор пациентов нуждающихся в имплантации систем… Читать ещё >
Содержание
- СПИСОК УСЛОВНЫХ СОКРАЩЕНИЙ
- ВВЕДЕНИЕ
- ГЛАВА I. ЛИТЕРАТУРНЫЙ ОБЗОР
- 1. 1. Состояние вопроса
- ГЛАВА II.
- 2. 1. 2.2. 2.2.2. 2
- ГЛАВА III.
- Принцип распределения донорских органов по UNOS
- Критерии отбора реципиентов в «лист ожидания» на трансплантацию сердца
- Механическая поддержка кровообращения
- КЛИНИЧЕСКАЯ ХАРАКТЕРИСТИКА
- БОЛЬНЫХ И МЕТОДЫ ИССЛЕДОВАНИЯ
- Клиническая характеристика пациентов
- Методы исследования
- Лабораторные методы исследования
- Инвазивные методы оценки центральной гемодинамики у пациентов с признаками легочной 54гипертензии
- РЕЗУЛЬТАТЫ ИССЛЕДОВАНИЯ
- ГЛАВА IV. ОБСУЖДЕНИЕ ПОЛУЧЕННЫХ РЕЗУЛЬТАТОВ
- ГЛАВА V.
Список литературы
- Беленков Ю.Н. Национальные рекомендации ВНОК И ОССН по диагностике и лечению ХСН (третий пересмотр)/Беленков Ю.Н., Васюк Ю. А., Галявич A.C. // Сердечная недостаточность. 2009.
- Бокерия JI.A. Лекции по кардиологии. // Актуальные вопросы диагностики и лечения терминальной сердечной недостаточности/ Бокерия Л. А., Голухова Е.З.// НЦССХ им. А. Н. Бакулева РАМН. 2001, № 2, с.146−147
- Бокерия Л.А., Лищук В. А., Газизова Д. Ш. Система показателей кровообращения для оценки состояния, выбора и коррекции терапии при хирургическом лечении ИБС (нозологическая норма). Руководство. М., 1998, 49 с.
- Бокерия О.Л. Ресинхронизационная терапия при застойной сердечной недостаточности мнение экспертов и предварительные результаты последних рандомезированных исследований//Анналы аритм.-2006.-№ 1 -с 1213- С14−17
- Бураковский В.И., Бокерия Л. А. Сердечно-сосудистая хирургия/ Бураковский В. И., Бокерия Л. А// Москва «Медицина». 1996. — стр. 610−612.
- Дерюгин М.В. Хронические миокардиты./ Дерюгин М. В., Бойцов С.А.// ЭЛБИ СПб. Санкт — Петербург 2005 г. с. 57 — 79.
- Слободяник В.В. Кардиоресинхронизирующая терапия в лечении терминальной стадии хронической сердечной недостаточности / Слободяник В. В., Лукава М. Г., Саитгареев Р. Ш., Шумаков Д.В.// Вестник трансплантологии и искусственных органов. 2007. № 2. С. 3—7.
- Хубутия М.Ш. Причины, ограничивающие длительное выживание после трансплантации сердца// Хубутия М. Ш., Казаков Э. Н., Кормер, А .Я.// Вестник трансплантологии и искусственных органов 2001, № 3 — Стр. 29−31.
- Шумаков В.И. Гемодинамика малого круга кровообращения у больных с дилатационной кардиомиопатией/ Шумаков В. И., Кормер А. Я., Казаков Э. Н., Шемакин С.Ю.// Кардиология 1994 № 7 — с. 43−46.
- Шумаков В.И. Дилатационная кардиомиопатия / Шумаков В. И., Хубутия М. Ш., Ильинский И.М./ЮОО «Издательство Триада», Москва 2003.
- Шумаков В.И. Искусственное сердце и вспомогательное кровообращение/ Шумаков В. И., Толпекин В. Е., Шумаков. Д.В.// Москва, Янус-К 2003.
- Шумаков В.И. Результаты трансплантации сердца у пациентов, ранее инфецированных вирусами гепатита В и С / Шумаков В. И., Губенко Т. В., Кормер А. Я., Казаков Э. Н. и др.// Вестник трансплантологии и искусственных органов. 2002, — № 1 — Стр. 7−11.
- Шумаков В.И. Трансплантация сердца. Москва «МИА» 2006. — стр. 30−37.
- Шумаков Д.В. Кардиоресинхронизирующая терапия терминальной стадии хронической сердечной недостаточности как «мост» к трансплантации сердца/ Шумаков Д. В., Слободяник В.В.//Вестник транспланталогии и искусственных органов. 2009. — Том 11 — № 4 — Стр. 713.
- Aaronson K., Schwartz J.S., Chen T., Mancini D. Development and-prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplantation. Circulation 1997- 95:2660−2667.
- Aaronson KD. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation/ Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM// Circulation 1997−95:2660−7.
- Adams JF., Lindenfeld J., Arnold J., et al. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 2006−12:el-el22.
- Amir O, Bracey AW, Smart FW, Delgado RM, Shah N, Kar B. A successful anticoagulation protocol for the first MeartMate II implantation in the United States. Tex Heart J. 2005−32(3):399−401.
- Arend Mosterdl, Arno W Hoes. Clinical epidemiology of heart failure. Heart 2007−93:1137−1146.
- Atsushi B., • Goichi Hirata, Fujio Yokoyama, • Kyouichi Kenmoku, Miyoko Tsuchiya, Shunei Kyo, Ryoichi Toyoshima. Psychiatric problems of heart transplant candidates with left ventricular assist devices. J Artif Organs 2006- 9:203−208.
- Aziz T. Cardiac transplantation for cardiomyopathy and ischemic heart disease: differences in outcome up to 10 years/ Aziz T, Burgess M, Rahman AN, Campbell CS, Yonan N. J// Heart Lung Transplant May 2001−20(5):525−33.
- Baughman KL. Diagnosis of myocarditis: death of Dallas, criteria/ Baughman KL.// Circulation.2006: 113: 593−595.
- Bethea B.T. Heart Transplantation / Bethea B.T., Yuh D.D., Conte J.V. et al. // Cohn LH, Edmunds LH Jr, eds. Cardiac Surgeryn the Adult. New York: McGraw-Hill, 2003. P. 1427- 1460.
- Carrier M, Rivard M, Latter D, KostukW. Predictors of early mortality after heart transplantation: the Canadian transplant experience from 1981 to 1992.
- The CASCADE Investigators. Canadian Study of Cardiac Transplant
- Atherosclerosis Determinants. Can J Cardiol 1998- 14:703−7.
- Chacko RC,. Harper RG, Kunik M- et al. Relationship of psychiatric morbidity and psychosocial factors in-organ transplant candidates. Psychosomatics 1996−37:100−107.
- Chatterjee K. Refractory heart failure drugs and devices/ Chatterjee K.// Eur Heart J 2001−22:2227−30
- Chen JM, Hammond KM, Kherani AR, et al. Is the alternate waiting list too high risk? The Columbia-Presbyterian experience. J Heart Lung Transplant 2003- 1S: S175.
- Cimato T. Recipient selection in cardiac transplantation: contraindications and risk factors for mortality/ Cimato T, Jessup M.// J Heart Lung Transplant 2002- 21: 1161−1173
- Costanzo Maria Rosa, MD, Chair- Sharon Augustine, MS, RN- Robert Bourge MD, Selection and Treatment of Candidates for Heart Transplantation. Circulation 1995- 92:3593−3612.
- Costanzo MR, Augustine S, Bourge R, et al. Selection and Treatment of Cardidates for Heart Transplantation. Circulation 1995- 92:3593−3612'.
- Costard-Jackie A, Hill I, Schroeder JS, et al. The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation 1991- 84(suppl III):III-329-III-337.
- Current U.S. Waiting List for Heart Transplant Candidates. Based on OPTN data as of January 1, 2007. Available at: http://www.optn.org/AR2006/waitlistoutcomes.htm. Accessed July 27, 2007.
- Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol, SI, Bader F, Krumholz HM. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005- 165:55−61.
- Davos CH. Body mass and survival1 in patients with chronic heart failure without cachexia: the importance of obesity/ Davos CH, DoehnerW, Rauchhaus M// J Card Fail 2003−9:29−35.
- Deng MC, Smits JMA, Packer M. Selecting patients for heart transplantation: which patients are too well for transplant? Curr Opin Cardiol. 2002−17:137−144
- Dew MA. Quality of life outcomes in left ventricular assist system inpatients and outpatients/ Dew MA., Kormos RL., Winowich S.// ASAIO J 1999: 45:218−25.
- Dubrey SW, Burke MM- Hawkins PN, Banner NR. Cardiac transplantation for amyloid heart disease: the United Kingdom experience. J Heart Lung Transplant. 2004−23(10):1142−53.
- El Banayosy A. Midterm follow — up of patients discharget from hospital under left ventricular assistance/ El — Banayosy A., Fey O, Sarnowski P.// J Heart Lung Transplant 2001 -20: 53−8.
- Fox K F, Cowie M R, Wood D A, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001- 22:228−36.
- Gallino A., Maggiorini M., Kiowski W., Martin X., Wunderli W., Schneider J., Turina M. and Follath F. Toxoplasmosis in heart transplant recipients. Eur. J. Clin. Microbiol., Infectious Diseases- Volume 15, Number 5 389−393.
- Grady KL. Change in quality of life from before to after discharge post left ventricular assist devices implantation/ Grady KL., Meyer PM., Dressier D.// J Heart Lung Transplant 2003−22: 322 33.
- Gupta S. Long-term follow-up of a heart transplant recipient with documented seroconversion to HIV-positive status 1 year after transplant/ Gupta S, Markham DW, Mammen PP, Kaiser P, Patel P5 Ring WS, Drazner MH. // Am J Transplant. 2008−8:893- 896.
- Habedanka Dirk, Ralf Ewertb, Manfred Hummelb, Roland Wenselc, Roland Hetzerb and Stefan D. Ankera, Changes in exercise capacity, ventilation, and body weight following heart transplantation. European Journal of Heart Failure 2007- 9(3):310−316.
- Hampton CR, Verrier ED: Systemic consequences of ventricular assist devices: alterations of coagulation, immune function, inflammation, and the neuroendocrine system. Artif 0rgans.2002−26(41):902−908.
- Horwich Tamara B., Gregg C. Fonarow, Michele A. Hamilton, W. Robb MacLellan, Maiy A. Woo, and Jan H. Tillisch. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001- 38:789−795.
- Hosotsubo KK, Nishimura M, Nishimura S. Hyperbilirubinaemia after major thoracic surgery: comparison between open-heart surgery and oesophagectomy. Crit Care 2000- 4:180−187.138
- Hunt SA, Baker DW, Chin MH, et al. The ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. Circulation 2001- 104:2996−3007.
- Hunt SA. Mechanical circulatory support: new data, old problems/ Hunt SA.// Circulation 2007- 116: 461 2.
- Hunt SA. Taking heart cardiac transplantation past, present, and future/ Hunt SA.// N Engl J1 Med 2006- 355:231 — 5.
- Hussain T, Burch M, Fenton MJ, et al. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children. Circulation 2007−115:1798−1805.
- Hussain T. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children/ Hussain T, Burch M, Fenton M J// Circulation 2007- 115:1798−805.
- Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). Available at: http://www.intermacs.org/membership.aspx.
- Jasom E., Curley L., David K. Wellisch. Psychiatric Evaluations of Heart Transplant Candidates: Predicting Post-Transplant Hospitalizations, Rejection Episodes, and Survival: Psychosomatics 47:213−222, May-June 2006.
- Jeffrey A. Morgan, MD, Ranjit John, MD, Donna M. Mancini, MD, Niloo M. Edwards, MD Should heart transplantation be considered as a treatment option for patients aged 70 years and older?. J Thorac Cardiovasc Surg 2004- 127:1 SHIS^.
- Kalil, A. C. Meta-Analysis: The Efficacy of Strategies To Prevent Organ Disease by Cytomegalovirus in Solid Organ Transplant Recipients/ Kalil, A. C., Levitsky, J., Lyden, E., Stoner, J., Freifeld, A. G.// ANN INTERN MED 2005- 143: 870−880
- Kalra PR. Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration/ Kalra PR., Sharma R., Shamin W.// Int J Cardiol. 2002- 122:528 534.
- Kawai C. From myocarditis to cardiomyopathy: mechanism of inflammation and cell death: learning from the past for the future/ Kawai C.// Circulation. 1999: 99: 1091−1100.
- Kelly DT. Our future society: A global challenge. Circulation. 1997−95:2459−2464
- Kelly M.C. Pulmonary arterial' hypertension/ Kelly M.C., Lewis J.R.// JACC Vol. 51, No. 16, April 22, 2008: 1527−38.
- Kempereman H. B type natriuretic peptide (BNP) and N — terminal pro BNP in patients with endLstage heart failure supported by a left ventricular assist devices/ Kempereman H., van den Berg M., Kirkels H.// Clin Chem 2004- 50- 1670−2.
- Kindermann I., MD. Predictor of outcome in patients with suspected myocarditis/ Kindermann I., MD., Kindermann M., MD., Kondolf R., MD.// Circulation Vol. 118, No. 6, August 5, 2008: 640−647.
- Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 1988- 7:331−336.
- Kishore, J. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome/ Kishore, J., Ghoshal, 140
- U., Ghoshal, U. C, Krishnani, N., Kumar, S., Singh, M., Ayyagari, K. I IJ Med Microbiol 2004- 53: 1155−1160
- Koglin J, Pehlivanli S, Schwaiblmair M, et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001 -38:1934−41.
- Komoda Takeshi, Roland Hetzer, Hans B. Lehmkuhl. Destiny of candidates- for heart transplantation in the Eurotransplant heart allocation system. European Journal of Cardio-thoracic Surgery 2008- 34:301—306.
- Kormos RL. Transplant candidates clinical status rather than right ventricular function defines need for univentricular versus biventricular support / Kormos RL., Gasior TA., Kawai A.// J Thorac Cardiovasc Surg 1996- 111: 773−83.
- Ladowski JS, Kormos RL, Uretsky BP, et al. Heart transplantation in diabetic recipients. Transplantation 1990- 49:303−305.
- Lahpor JR. Left ventricular, assist devices as bridge to transplantation, in patients with end-stage heart failure/ Lahpor JR., Jonge N., Swieten H.A.// Neth Heart J 2002:10: 267−71/
- Lang C. Morbidity and mortality in diabetic patients following cardiac transplantation/ Lang C, Beniaminovitz A, Edwards N, Mancini D'.// J Heart Lung Transplant. 2003−22:244−249.
- Lang C. Peak cardiac power output measured non-invasively, is a powerful predictor of outcome in chronic heart failure/ Lang C, Karlin P, Haythe J, Lim T, Mancini D.// Circ Heart Fail. 2009−2:33−38.
- Lietz K., John R., Burke E.A., et al. Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation 2001 — 72:277−283.
- Light RW, George RB. Serial pulmonary function in patients with acute heart failure. Arch Intern Med. 1983−143:429−433.
- Lin CH, Lin FY, Wang SS, Yu HY, Hsu RB. Cardiac surgery in patients with liver cirrhosis. Ann Thorac Surg 2005−79:1551−1554.
- Louie HW. Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation/ Louie HW, Laks H, Milgalter E.// Circulation. 1991 Nov-84(5 Suppl):III290−5.
- Lund L. Predicting survival in ambulatory patients with severe heart failure on beta blocker therapy/ Lund L, Aaronson K, Mancini D. // Am J Cardiol. 2003−92:1350 -1354.
- Maisel A. B-type natriuretic peptide levels: a potential novel «white counf’for congestive heart failure. J^Card Fail. 2001−7:183−193.
- MancinL D. Value of peak exercise oxygen- consumption' for optimal timing of cardiac transplantation in ambulatory patients with heart failure/ Mancini D, Eisen H, Kussmaul-W, Mull R.// Circulation. 1991−83:778 -786.
- Mc Griffin DC, Kirklin JK, Naftel DC, et al. Acute renal failure after heart transplantation and cyclosporin therapy. J Heart Transplant 1985- 4:396−399.
- McAlister FA., Cardiacsynchronization therapy for patients with left ventricular systolic dysfunction: a systematic rewiew/ McAlister FA., Ezekowitz J., Hooton N./ JAMA. 2007- 297:2502 2514/
- OO.McCullough P., Nowak R., McCord J. et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Circulation 2002- 106: 416−420.
- Miller Leslie, Heart-Transplantation in Patients with Diabetes. Circulation 2006- 114:2206−2207.
- Miller LW, Kubo SH, Young JB, et al: Report of the Consensus Conference on Candidate Selection for Heart Transplantation: 1993. J Heart Lung Transplant 1995- 14:562−571.
- Mokadam NA, Ewald GA, Damiano RJ, Moazami N. Deterioration and mortality among patient with United Network for Organ Sharing status 2 heart disease: caution must be exercised in diverting organs. J Thorac Cardiovasc Surgery. 2006−131:925−926.
- Morgan, Jeffrey A. Heart transplantation in diabetic recipients: A decade review of 161 patients at Columbia Presbyterian/ Jeffrey A. Morgan, MD, Ranjit John, MD, Alan D. Weinberg, MS// J Thorac Cardiovasc Surg 2004- 127:14 861 492
- Munoz E, Lonquist JL, Radovancevic B, et al. Long-term result in diabetic patients undergoing heart transplantation. J Heart Lung Transplant-1992- 11:943 949.
- Murali S. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience/ Murali S, Kormos R, Uretsky B.// Am Heart J. 1993−126:896 -904.
- Pae WE, Connell’JM, Boehmer JP, et al. Neurologic events with a, totally implantable left ventricular assist device: European LionHeart clinical utility baseline study. J Heart Lung Transplant: 2007−26(1): 1−7.
- Patel N. D: Impact of donor to — recipient weight ratio on survival after heart transplantation/ Patel N.D., Weiss E.S., Nwakanma L. U// Circulation 2008- 118: S83−87.
- Paya, C. V. 2001. Prevention of cytomegalovirus disease in recipients of solid-organ transplants. Clin. Infect. Dis. 32:596−603.
- Raymond RJ. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension/ Raymond RJ., Hinderliter AL, Willis PW.// JACC 2002−39: 1214−9.
- Rickenbacher PR, Lewis NP, Valantine HA, Luikart H, Stinson EB, Hunt SA. Heart transplantationdn patients over 54 years of age. Mortality, morbidity and- quality of life. Eur Heart J 1997- 18:870−878.
- Rose E, Gelijns A, Moskowitz A, et al. Long term use of left ventricular device forend-stage heart failure. (REMATCH). N Engl J Med 2001- 345:14 351 443.
- Rosse RM. Hepatic dysfunction secondary to heart failure / Rosse RM.// Am J Gastroenterol 1981 — 76: 511 8.
- Sawyer DB, Skinner M. Cardiac amyloidosis: shifting our impressions tohopeful. Curr Heart Fail Rep 2006- 3(2):64—71.
- Schmid C, Weyand M, Nabavi DG, Hammel D, Deng MC, Ringelstein EB, Scheld HH. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg 1998−65:1703−1710.
- Scientific Registry of Transplant Recipients. Website: www.ustransplant.org.
- Sean R. Wilson. Evaluation for a Ventricular Assist Device./ Sean R. Wilson, Gilbert H. Mudge, Jr, Garrick C. Stewart, Michael M. Givertz.// Circulation 2009- 119:2225−2232.
- Stevenson L. Clinical use of inotropic therapy for heart failure: looking backwards and forward, part II: chronic inotropic therapy. Circulation. 2003−108:492−497.
- Szlachcic J, Massie B, Kramer B, et al. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985- 55: 1037−1042.
- Taylor DO, Edwards LB, Boucek MM, et al. Registry of the1. ternational Society for Heart and Lung Transplantation: twentyfourth officialadult heart transplant report—2007. J Heart Lung Transplant 2007- 26:769 81. f
- Tjang Y.S., Predicting Outcome Of Heart Transplantation, Universiteit Utrecht, Netherlands, 2008.
- Tjang YS. Impact of recipient’s age on heart transplantation outcome/ Tjang YS, van der Heijden GJ, Tenderich G, Ko’rfer R, Grobbee DE. // Ann Thorac Surg. 2008−85:2051−2055.
- Wang TJ. Plasma natriuretic peptide levels and risk of cardiovascular events and death/ Wang TJ., Larson MG., Levy D.// N Engl J Med 2004−350:655−63.
- Weber K, Kinasewitz G, Janicki J, et al. Oxygen utilization and ventilation during exercise in patients with chronic congestive heart failure.// Circulation 1982- 65:1213−1223.
- Young B. Heart Failure’s Near Dead and Dying: Reconsidering Our Heart Transplant Wait List / Scheme James B. Young J. Am. Coll. Cardiol. 2007−50- 1291−1293.1353.